Quantcast
Last updated on April 18, 2014 at 8:27 EDT

Latest Oncologists Stories

2013-08-12 08:28:21

ROCKVILLE, Md., Aug. 12, 2013 /PRNewswire/ -- MacroGenics, Inc. today announced that it has appointed Jon Wigginton, M.D., as Senior Vice President, Clinical Development. Dr. Wigginton most recently held dual leadership roles at Bristol-Myers Squibb in clinical development and discovery research of its oncology programs. "We are thrilled to welcome Jon to our team. He has demonstrated significant expertise in clinical development of oncology candidates throughout his years as both a...

2013-08-01 23:03:58

The Oncology Institute of Hope and Innovation welcomes Dr. Michael Chung to their team of specialists. Downey, California (PRWEB) August 01, 2013 Dr. Chung grew up around Washington D.C. He attended the Thomas Jefferson High School for Science and Tech and went on to college at Cornell University, where he also became a certified EMT and first responder. He worked in the Food Science laboratories as a Pre-Med and graduated Magna Cum Laude with a degree in Computer Science. Dr. Chung...

2013-07-31 08:29:27

CAMBRIDGE, Mass., July 31, 2013 /PRNewswire/ -- Moderna Therapeutics, the pioneering company developing messenger RNA therapeutics(TM), a revolutionary new treatment modality to enable the in vivo production of therapeutic proteins, announced today that Joseph Bolen, Ph.D., joined Moderna as its president of research and development (R&D). Dr. Bolen, the chief scientific officer and global head of oncology research at Millennium: The Takeda Oncology Company has served in senior...

2013-07-24 04:22:01

SEATTLE, July 24, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that Daniel D. Von Hoff, M.D., F.A.C.P, a leading medical oncologist who has been the lead investigator in the development of important oncology therapeutics, will serve as Chairman of CTI's Scientific Advisory Board. The purpose of the Scientific Advisory Board will be to assist management in the strategic development of its oncology portfolio and clinical trial design; work...

2013-07-12 23:31:58

Dr. Arthur Brown, Chief & Medical Director for Employee Health & Wellness Services at Memorial Sloan Kettering Cancer Center, will deliver the keynote address at the 2013 Medgate User Group Conference. Up to 200 OHS professionals from many leading organizations will gather at this conference to discuss best practices in OHS data management. (PRWEB) July 11, 2013 Medgate is pleased to announce Dr. Arthur E. Brown as the keynote speaker for its 2013 User Group Conference (UGC). Dr....

2013-07-12 08:23:52

Conference called scheduled for Wednesday, August 14, 2013 at 10 a.m. EDT WORCESTER, Mass. and TORONTO, July 12, 2013 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced particulars of the conference call it will be hosting featuring members of the Antigen Express, Inc. (www.antigenexpress.com) Scientific Advisory Board. The conference call will take place on Wednesday, August 14, 2013 at 10 a.m. EDT. Call-in particulars will be...

2013-07-10 12:28:06

"Oncology Protocol Challenge" and New Appointments Underscore Commitment to Cancer Studies ROCKVILLE, Md., July 10, 2013 /PRNewswire-USNewswire/ -- This spring has seen Accelovance, a Rockville, Md. Clinical Research Organization (CRO) serving biotech and small and mid-sized pharmaceutical companies, advance its goal of providing premier services within oncology clinical research. The company successfully completed its first-ever "Oncology Protocol Challenge" at the American...

2013-07-08 16:26:49

BELLEVILLE, ON, July 8, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced the outcome of a meeting in late June with Health Canada, at which time the Company discussed the filing of a regulatory submission for its Phase III bladder cancer product - Urocidin(TM) - under Health Canada's Notice of Compliance with Conditions (NOC/c) policy. Health Canada advised the Company...

2013-07-08 12:28:21

CHICAGO, July 8, 2013 /PRNewswire/ -- The American Association of Clinical Urologists (AACU), American Urological Association (AUA), and Large Urology Group Practice Association (LUGPA) today applauded the 17 members of the Physician's Caucus of the United States House of Representatives who demonstrated their commitment to preserving patient access to independent, integrated medical services. In a letter to Speaker John Boehner and Democratic Leader Nancy Pelosi, dated June 28,...

2013-06-28 12:24:26

SAN DIEGO, June 28, 2013 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today that Roche received a positive recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for the subcutaneous formulation of Herceptin(®) (trastuzumab) using Halozyme's recombinant human hyaluronidase (rHuPH20) for the treatment of patients with HER2-positive breast cancer in Europe. (Logo;...